After intersecting the angiogenesis-related genes and the target of salidroside in the treatment of CAD, 12 genes remained, including VEGFA, KDR, CD34, FGF2, AKT1, FGF1, IL10, TEK, CCND2, IL32, HLA-C, and HIF1A. This evidence concerns the gene CCND2 and coronary artery disorder.